<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="83996">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01918449</url>
  </required_header>
  <id_info>
    <org_study_id>PI12/01499</org_study_id>
    <nct_id>NCT01918449</nct_id>
  </id_info>
  <brief_title>Follow-up of Patients With Obstructive Sleep Apnea in Primary Care.</brief_title>
  <official_title>Follow-up of Patients With the Apnea-hypopnea Syndrome in Primary Care and Sleep Disorders Units. Equivalence Randomized Comparative Study on Compliance and Clinical Response.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sociedad Española de Neumología y Cirugía Torácica</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundacio Catalana de Pneumologia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sociedad Española de Neumología y Cirugía Torácica</source>
  <oversight_info>
    <authority>Spain: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to compare the results of a coordinated and interactive
      program for the treatment, monitoring and control of patients with a moderate-severe
      diagnosis of Obstructive Sleep Apnea (OSA) and treated with positive continuous  pressure
      (CPAP), with the currently established situation.

      Methodology: Equivalence randomized comparative study . It  will include patients with
      diagnosis of moderate-severe OSA (apnea-hypopnea Index &gt;=15) that should start treatment
      with (CPAP). Participating center is Hospital Santa María-Arnau de Vilanova in Lleida
      (Spain).These patients will be randomized to two monitoring groups (1: monitoring in the
      Sleep disorders unit,  2: monitoring in primary care consultations) once the OSAS diagnosis
      has been made and it was indicated that treatment with CPAP. Patients Will be carried out in
      both groups the same follow-up visits in two study arms: basal, 1 month, 3 months and 6
      months. Primary outcomes: number of hours of use per day (according to the accountant of the
      CPAP), so that use &gt;= 4h/day is defined as good adherence to the treatment. Secondary
      outcomes:  daytime sleepiness, patient satisfaction, Adverse events related to CPAP
      treatment. It will be collected demographic ,clinics and anthropometric variables. At the
      end of follow-up primary and secondary outcomes will be compared between two groups.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Number of hours of use per day of CPAP</measure>
    <time_frame>Six month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Number of hours of use per day of CPAP according to the internal clock of the CPAP device</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Daytime sleepiness</measure>
    <time_frame>At baseline and at 6 month of follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>Epworth Sleepiness Scale (ESS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>Six month</time_frame>
    <safety_issue>No</safety_issue>
    <description>visual analog scale (0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>Six month</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Adverse events related to CPAP treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Baseline and at 6 month of follow up</time_frame>
    <safety_issue>No</safety_issue>
    <description>EuroQol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-efficacy evaluation</measure>
    <time_frame>Six month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Qualys</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comorbidity index</measure>
    <time_frame>Six month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Charlson index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Sixt month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Office blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lost of follow up</measure>
    <time_frame>Six month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Percentage of patients lost during follow up</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Body mass index</measure>
    <time_frame>Six month</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>OSA</condition>
  <arm_group>
    <arm_group_label>Sleep Unit group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will have standard follow up in sleep unit at 1, 3 and month. These patients will also be instructed in hygienic-dietary measures, standard care of cardiovascular risk factors and sleep hygiene counseling.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Primary Care group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will have standard follow up in primary care at 1, 3 and month. These patients will also be instructed in hygienic-dietary measures, standard care of cardiovascular risk factors and sleep hygiene counseling.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clinical follow up by general practitioners in primary care</intervention_name>
    <description>The study evaluates two different setting to follow up patients with obstructive sleep apnea on CPAP treatment</description>
    <arm_group_label>Primary Care group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women over 18 years old.

          -  Patients with OSA diagnosis performed in the sleep units

          -  Written informed consent signed.

        Exclusion Criteria:

          -  Previous CPAP treatment for OSA diagnosis

          -  Psycho-physical inability to complete questionnaires.

          -  Presence of any previously diagnosed sleep disorders: narcolepsy, insomnia, chronic
             sleep deprivation, regular use of hypnotic or sedative medications and restless leg
             syndrome

          -  Patients with respiratory diseases (overlap syndrome, hypoventilation, restrictive
             diseases)

          -  A medical history that may interfere with the study objectives or, in the opinion of
             the investigator, compromise the conclusions.

          -  Any medical factor, social or geographical, that may jeopardize patient
             compliance.(e.g., alcohol consumption (more 80 gr/day in men and more than 60 gr /
             day in women), no fixed address, disorientation, or a history of non-compliance).
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ferran Barbe, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Anrnau Vilanova- Santa Maria, Lleida (Spain)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cristina Esquinas, RN, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Arnau Vilanova-Santa Maria, Lleida (Spain)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nuria Nadal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Primary Care. National Health Institute. Lleida (Spain)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ferran Barbe, MD</last_name>
    <phone>34973705372</phone>
    <email>febarbe.lleida.ics@gencat.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cristina Esquinas, RN, MPH</last_name>
    <phone>34658865112</phone>
    <email>crise4@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital santa Maria</name>
      <address>
        <city>Lleida</city>
        <state>Catalonia</state>
        <zip>25198</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Esquinas, RN, MSP</last_name>
      <phone>34973705372</phone>
      <email>crise4@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Ferran Barbe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristina Esquinas, RN, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manuel Sanchez de la Torre, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nuria Nadal, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>May 13, 2014</lastchanged_date>
  <firstreceived_date>July 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sociedad Española de Neumología y Cirugía Torácica</investigator_affiliation>
    <investigator_full_name>Ferran Barbe</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>OSA</keyword>
  <keyword>CPAP treatment</keyword>
  <keyword>primary care</keyword>
  <keyword>efficacy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
